These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3667024)

  • 41. Hypotensive action of verapamil in a group of hydralazine-dependent hypertensive patients.
    González-Gómez A; Gamio-Capestany F; García-Barreto D
    Arch Int Pharmacodyn Ther; 1983 Feb; 261(2):268-77. PubMed ID: 6838286
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction between oral verapamil and beta-blockers during submaximal exercise: relevance of ancillary properties.
    Bailey DG; Carruthers SG
    Clin Pharmacol Ther; 1991 Apr; 49(4):370-6. PubMed ID: 2015727
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hemodynamic and metabolic responses to exercise after alpha 1-, beta 1-, and nonselective beta-adrenoceptor blockade in man.
    McLeod AA; Brown JE; Kitchell BB; Sedor FA; Kuhn DC; Williams RS; Shand DG
    Am J Med; 1984 Feb; 76(2A):97-100. PubMed ID: 6702866
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of beta 1-selective and non-selective beta-blockade on work capacity and muscle metabolism.
    Kaiser P; Tesch PA; Frisk-Holmberg M; Juhlin-Dannfelt A; Kaijser L
    Clin Physiol; 1986 Apr; 6(2):197-207. PubMed ID: 3006981
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Twice-daily verapamil for hypertension: a comparison with propranolol.
    Hornung RS; Jones RI; Gould BA; Sonecha T; Raftery EB
    Am J Cardiol; 1986 Feb; 57(7):93D-98D. PubMed ID: 3513519
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of the effects of guanadrel sulfate and propranolol on blood pressure, functional capacity, serum lipoproteins and glucose in systemic hypertension.
    Darga LL; Hakim MJ; Lucas CP; Franklin BA
    Am J Cardiol; 1991 Mar; 67(7):590-6. PubMed ID: 2000792
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of verapamil on cardiovascular and metabolic responses to exercise.
    Petri H; Arends BG; van Baak MA
    Eur J Appl Physiol Occup Physiol; 1986; 55(5):499-502. PubMed ID: 3095111
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combination of verapamil and beta blockers in systemic hypertension.
    Dargie H; Cleland J; Findlay I; Murray G; McInnes G
    Am J Cardiol; 1986 Feb; 57(7):80D-82D. PubMed ID: 3513518
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Verapamil and propranolol: a comparison of two antihypertensive agents.
    Leonetti G; Pasotti C; Ferrari GP; Zanchetti A
    Acta Med Scand Suppl; 1984; 681():137-41. PubMed ID: 6587752
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modification of the metabolic and hormonal response to physical exercise by beta-blocking agents.
    Uusitupa M; Siitonen O; Härkönen M; Gordin A; Aro A; Hersio K; Johansson G; Korhonen T; Rauramaa R
    Ann Clin Res; 1982; 14 Suppl 34():165-7. PubMed ID: 6756273
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of propranolol and of verapamil on heart rate and blood pressure in hyperthyroidism.
    Clozel JP; Danchin N; Genton P; Thomas JL; Cherrier F
    Clin Pharmacol Ther; 1984 Jul; 36(1):64-9. PubMed ID: 6734051
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of antihypertensive medication on endurance exercise capacity in hypertensive sportsmen.
    Vanhees L; Fagard R; Lijnen P; Amery A
    J Hypertens; 1991 Nov; 9(11):1063-8. PubMed ID: 1661765
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of potential pharmacodynamic and pharmacokinetic interactions between verapamil and propranolol in normal subjects.
    Murdoch DL; Thomson GD; Thompson GG; Murray GD; Brodie MJ; McInnes GT
    Br J Clin Pharmacol; 1991 Mar; 31(3):323-32. PubMed ID: 2054272
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of propranolol on catecholamine concentration in blood of normotensive man during physical exercise and dependence of the drug effect on dosage intervals.
    Planz G; Planz R
    Arch Int Pharmacodyn Ther; 1980; Suppl():58-66. PubMed ID: 7416879
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antihypertensive effect of propranolol at rest and during exercise.
    Leenen FH; Boer P; Dorhout Mees EJ
    Br J Clin Pharmacol; 1983 Mar; 15(3):361-5. PubMed ID: 6342641
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Propranolol versus verapamil for the treatment of essential hypertension.
    Hornung RS; Jones RI; Gould BA; Sonecha T; Raftery EB
    Am Heart J; 1984 Sep; 108(3 Pt 1):554-60. PubMed ID: 6382991
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of acute or chronic ingestion of propranolol or metoprolol on the physiological responses to prolonged, submaximal exercise in hypertensive men.
    Wilcox RG; Bennett T; Macdonald IA; Herbert M; Skene AM
    Br J Clin Pharmacol; 1984 Mar; 17(3):273-81. PubMed ID: 6712861
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antihypertensive and renal effects of orally administered verapamil.
    Leonetti G; Sala C; Bianchini C; Terzoli L; Zanchetti A
    Eur J Clin Pharmacol; 1980 Nov; 18(5):375-82. PubMed ID: 7002568
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Metabolic effects of chlorothiazide and propranolol on essential hypertension--a double-blind, cross-over design clinical trial].
    Chu NF; Wang DJ; Chen LM; Ding YA; Shieh SM; Sung PK
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Feb; 47(2):101-9. PubMed ID: 1848131
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of long-term anti-hypertensive beta-receptor-blocking treatment on haemodynamic and metabolic responses to prolonged exercise in man.
    Frisk-Holmberg M; Juhlin-Dannfeldt A; Jorfeldt L; Aström H
    Clin Sci Mol Med Suppl; 1976 Dec; 3():489s-491s. PubMed ID: 1071668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.